Clinical trial
A Study of Retreatment With MabThera (Rituximab) in Combination With…
NCT00422383 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00422383 |
|---|---|
| Title | A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA) |
| Official title | A Randomized, Double-blind Study to Evaluate the Effect of Various Re-treatment Regimens of MabThera in Combination With Methotrexate on Treatment Response in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | rituximab [MabThera/Rituxan] |
| Enrollment | 378 |
| Start date | Feb 1, 2006 |
| Primary completion | Mar 1, 2013 |
| Completion | Mar 1, 2013 |
| First posted | Jan 17, 2007 |
| Last update posted | May 4, 2015 |
| Countries | Australia, Belgium, Brazil, Canada, China, Finland, France, Germany, Hungary, Italy, Netherlands, New Zealand and 6 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: